Primary Advanced Unresectable Pancreatic Cancer
Authors:
- 31 December 2007
- book chapter
- Published by Springer Nature
- Vol. 177, 79-93
Abstract
Median as well as overall survival of pancreatic cancer patients in the advanced stage is extremely low despite advances in cancer therapy regarding tumor cell biology, therapy resistance, and diagnosis. In matters of chemoradiation therapy (CRT) in locally advanced pancreatic cancer, favorable positive effect has been reached with different radiotherapy proceedings such as intraoperative radiation therapy with or without external chemo-/radiation therapy or with CRT alone with regard to local tumor pain, local tumor remission, or local control of disease and overall survival. Primary (chemo-) radiation therapy only rarely leads to local remission. Intraoperative radiation therapy (IORT) merely reaches pain palliation in most cases. By administering up-to-date primary CRT, especially with gemcitabine-associated CRT, local remission in up to 50% of patients can be observed.Keywords
This publication has 98 references indexed in Scilit:
- Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
- Chemoradiotherapy in the Treatment of Regional Pancreatic CarcinomaAmerican Journal of Clinical Oncology, 2003
- Surgical resection following radiation therapy with concurrent gemcitabine in patients with previously unresectable adenocarcinoma of the pancreasJournal of Gastrointestinal Surgery, 2003
- Hyperfractionated radiotherapy and paclitaxel for locally advanced/unresectable pancreatic cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2003
- Surgical Resection After Preoperative Chemoradiotherapy Benefits Selected Patients With Unresectable Pancreatic CancerAmerican Journal of Clinical Oncology, 2003
- Treatment of Unresectable, Locally Advanced Pancreatic Adenocarcinoma with Combined Radiochemotherapy with 5-Fluorouracil and CisplatinPancreas, 2002
- Phase III Study of Gemcitabine in Combination With Fluorouracil Versus Gemcitabine Alone in Patients With Advanced Pancreatic Carcinoma: Eastern Cooperative Oncology Group Trial E2297Journal of Clinical Oncology, 2002
- Hospital Volume and Surgical Mortality in the United StatesNew England Journal of Medicine, 2002
- Phase I Trial of Twice-Weekly Gemcitabine and Concurrent Radiation in Patients With Advanced Pancreatic CancerJournal of Clinical Oncology, 1999
- Intraoperative Radiation Therapy for Carcinoma of the Stomach and Pancreas1991